1) Strategic Developments and Leadership Insights
- Healthpeak Properties executed a significant acquisition at the Gateway campus in South San Francisco, signing 62,000 square feet of leases and having 113,000 square feet in proposals and tours.
- The IPO of the senior housing business raised $240 million, with Healthpeak maintaining substantial exposure to the sector.
- The company repurchased $100 million of stock in April, which is expected to be accretive to earnings and reflects management's belief that the stock is undervalued.
- Healthpeak's outpatient platform is gaining recognition in the private market, evidenced by a joint venture with Blackstone that raised $170 million.

2) Financial Performance and Segment Results
- Reported FFO as adjusted of $0.45 per share, with a net debt-to-EBITDA ratio of 5.4x.
- Outpatient Medical segment showed strong fundamentals with a 5.4% cash re-leasing spread and 91% total occupancy.
- Senior Housing reported a 35% revenue growth and 42% adjusted EBITDA growth, driven by the Janus Living IPO.
- Life Science occupancy increased to 77.7%, with expectations for further growth by year-end 2026.

3) Operational Plans and Market Dynamics
- Healthpeak is advancing strategic outpatient developments with health system partners, although details are not yet public.
- The company is focused on capturing occupancy growth in the Life Science segment, with a robust pipeline of leasing activity.
- The leasing pipeline includes 318,000 square feet executed since April, with an additional 700,000 square feet under letters of intent.
- The company aims to maintain a disciplined approach to capital allocation, focusing on high-quality opportunities.

4) Challenges and Headwinds
- The company anticipates a $20 million increase in interest expenses and a $5 million increase in G&A, which could pressure margins.
- The IPO's impact on earnings is expected to be neutral in 2026 due to incremental public company costs and temporary earnings drag from cash on the balance sheet.
- Healthpeak is cautious about opportunistic investments in life sciences, maintaining a high threshold for capital deployment.

5) Guidance and Outlook
- Healthpeak raised its 2026 FFO guidance to a range of $1.71 to $1.75 per share, reflecting confidence in operational performance despite headwinds.
- The company expects the IPO proceeds to be accretive to Healthpeak by approximately $0.04 per share once fully invested and stabilized.
- There is a focus on achieving net absorption in both outpatient and life science segments, with a positive trajectory expected.

Bottom line: Healthpeak Properties is strategically positioned for growth with strong fundamentals across its segments, particularly in outpatient medical and senior housing. The recent IPO and acquisitions are expected to enhance shareholder value, despite some near-term challenges related to costs and market conditions.